Use the online tool to search for medical information about Sanofi US drugs.
Sanofi-aventis U.S. is committed to funding high quality educational activities and materials in the therapeutic
areas of interest to the company that have the potential to improve patient care and health outcomes.
Sanofi is committed to supporting medically and scientifically sound research aimed at advancing knowledge of diseases and their
treatments with a goal of advancing patient care in therapeutic areas in which Sanofi has experience and interest.
Please fill out and submit the fields below with the information required or contact us at 1-866-662-6411.
The content of this site is provided for general educational purposes only and should not be considered legal, financial or practice advice.
You should exercise independent judgment before applying any information to your own practice needs.
Third-party information provided represents the point of view of the writers and not the opinion of Sanofi.
This site is intended for U.S. Healthcare Professionals only
© 2005-2016 sanofi-aventis U.S. LLC. All rights reserved.
Legal Notices and Disclaimers
US.ONP.13.06.001 Last updated: July 2013
Sanofi joins the fight against prostate cancer
ON THE LINE is a prostate cancer awareness campaign and Sanofi is co-sponsoring this initiative to help educate men and women about the importance of prostate screening. The campaign focuses on health education that harnesses the power of sports and celebrities to challenge men to take charge of their health. ON THE LINE offers educational materials for both men and women on prostate cancer, to promote a true "team" approach.
And Sanofi is fighting prostate cancer every way we can too. We know the stakes. Prostate cancer is the most commonly diagnose cancer in American men today. Every five minutes two more men are diagnosed with the disease. And it's the second leading cause of cancer death in the U.S.
From our earliest days, the goals of our cancer research have remained steadfast: to battle cancer with the most effective agents we can develop, to reduce the side effects of chemotherapy and to create breakthrough therapies for cancer patients. With the availability of new research techniques, we are also investigating targeted agents and novel approaches that may one day play an important role in advancing cancer management.
For more information about ON THE LINE, visit www.ontheline.com.
Share the fight against prostate cancer. Visit ON THE LINE on Facebook and YouTube